Robbins Arroyo LLP Is Investigating the Officers and Directors of American Renal Associates Holdings, Inc. (ARA) on Behalf of Shareholders
Robbins Arroyo LLP is investigating whether certain officers and directors of American Renal Associates, Inc. (NYSE: ARA) violated applicable laws by causing the company to engage in health insurance fraud. American Renal Associates (“ARA”) operates as a dialysis services provider in the United States focused exclusively on joint venture partnerships with physicians.
American Renal Associates Is Investigated for Health Insurance Fraud
ARA has been accused of engaging in a fraudulent and illegal scheme to obtain benefit payments from UnitedHealthcare of Florida, Inc., UnitedHealthcare of Ohio, Inc. and All Savers Insurance Company (collectively, “United”) for dialysis services rendered to patients suffering from end-stage renal disease. ARA specifically targeted Medicaid- and Medicare-eligible patients to convince them to drop or reject their affordable government insurance options and enroll in United’s commercial plans in order to maximize the company’s own profits. Medicare and Medicaid pay ARA a reimbursement rate of $300 or less for one session of dialysis services rendered to a patient, but because ARA does not have a contractually agreed upon rate for United’s commercial plans, it has allegedly billed United up to twenty times the rate it would receive from Medicaid and Medicare. United has paid millions of dollars in benefits to ARA for claims ARA submitted as part of its unethical conversion and billing scheme.
American Renal Associates Shareholders Have Legal Options
Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, or you can complete the form below and we will contact you directly.
Send This Post